GE Healthcare to invest in Pulsenmore to enter homecare segment
GE will collaborate with Pulsenmore to supply its products in Europe and various other markets.

GE will collaborate with Pulsenmore to supply its products in Europe and various other markets.
The FDA-cleared ReGrasp Bionic Glove can be used to improve hand function after stroke or injury.
The point-of-care test can distinguish benign from malignant ovarian cysts in an operating theatre setting.
The CAPTIS device is designed to lessen the risk of stroke and other complications during catheter-based heart surgeries.
The Aptima CMV Quant assay was approved to quantify the viral load of CMV among transplant recipients.
The study will enrol people with SCI suffering from orthostatic hypotension.
The CE marking will enable Lucira to sell and distribute the two tests throughout the EU.
The collaboration seeks to improve access to personalised cancer care using 3D printed medical devices.